ELVNYSEhealth care

Elevance Health, Inc.

$425.17上涨+8.94 (+2.15%)

研究复核截至: 2026年7月12日上午12:00 [UTC]

研究概览

Elevance Health, Inc. operates in Managed Health Care within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

開盤: 422.46
最高: 426.46
最低: 419.62
市值: 923.31億
本益比: 18.02
52 週高點: --
股息: 1.650%
季度股利金額: --

近 3 个月价格

這裡展示近 3 個月價格走勢，幫助使用者先理解短期結構，再決定是否進入完整研究工作台。

投资论点

基础情景: Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients. The base case remains conditional on medicaid rate adequacy staying manageable.
多头情景: Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients. Disciplined pricing and product design can preserve margins as utilization changes. Scale in Medicaid and Medicare can support membership relationships when rates reflect care costs.
空头情景: State rates may lag acuity changes after eligibility redeterminations, compressing margins. Higher outpatient, pharmacy or specialty-care use can exceed premium assumptions. Payment rules, risk adjustment and benefit mandates can alter product economics.
论点失效条件: Reassess the thesis if state rates may lag acuity changes after eligibility redeterminations, compressing margins.

关键催化剂

Carelon expansion
Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients.
Commercial pricing
Disciplined pricing and product design can preserve margins as utilization changes.
Government programs
Scale in Medicaid and Medicare can support membership relationships when rates reflect care costs.

主要风险

Medicaid rate adequacy
State rates may lag acuity changes after eligibility redeterminations, compressing margins.
Medical utilization
Higher outpatient, pharmacy or specialty-care use can exceed premium assumptions.
Regulatory exposure
Payment rules, risk adjustment and benefit mandates can alter product economics.

估值解读

A managed-care quality premium requires rate adequacy and underwriting discipline across both commercial and government books.
Carelon diversification is more valuable when external growth is visible and not solely dependent on affiliated plan volume.